VIBATIV (Telavancin Hydrochloride) Pregnancy Exposure Registry.
Phase of Trial: Phase IV
Latest Information Update: 29 Jun 2016
At a glance
- Drugs Telavancin (Primary)
- Indications Enterococcal infections; Nosocomial pneumonia; Skin and soft tissue infections; Staphylococcal infections; Streptococcal infections
- Focus Adverse reactions
- Sponsors Astellas Pharma; Innoviva
- 24 May 2010 New trial record.